{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T11:49:23Z","timestamp":1783424963144,"version":"3.54.6"},"reference-count":191,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,2,25]],"date-time":"2023-02-25T00:00:00Z","timestamp":1677283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,25]],"date-time":"2023-02-25T00:00:00Z","timestamp":1677283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Braz J Microbiol"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s42770-023-00936-0","type":"journal-article","created":{"date-parts":[[2023,2,25]],"date-time":"2023-02-25T05:02:38Z","timestamp":1677301358000},"page":"907-919","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Non-self glycan structures as possible modulators of cancer progression: would polysaccharides from Cryptococcus spp. impact this phenomenon?"],"prefix":"10.1007","volume":"54","author":[{"given":"Israel","family":"Diniz-Lima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo Marques","family":"da Fonseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jhenifer Santos","family":"Dos Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debora","family":"Decote-Ricardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Morrot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Osvaldo","family":"Previato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia Mendon\u00e7a","family":"Previato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celio Geraldo","family":"Freire-de-Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3013-3173","authenticated-orcid":false,"given":"Leonardo","family":"Freire-de-Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,25]]},"reference":[{"issue":"14","key":"936_CR1","doi-asserted-by":"publisher","first-page":"7086","DOI":"10.3390\/app12147086","volume":"12","author":"I Diniz-Lima","year":"2022","unstructured":"Diniz-Lima I, Fonseca LMd, Silva-Junior EBd, Guimar\u00e3es-de-Oliveira JC, Freire-de-Lima L, Nascimento DO et al (2022) Cryptococcus: history, epidemiology and immune evasion. Appl Sci 12(14):7086. https:\/\/doi.org\/10.3390\/app12147086","journal-title":"Appl Sci"},{"issue":"1","key":"936_CR2","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1080\/21505594.2019.1614383","volume":"10","author":"O Zaragoza","year":"2019","unstructured":"Zaragoza O (2019) Basic principles of the virulence of Cryptococcus. Virulence 10(1):490\u2013501. https:\/\/doi.org\/10.1080\/21505594.2019.1614383","journal-title":"Virulence"},{"issue":"6","key":"936_CR3","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3390\/medicines9060037","volume":"9","author":"I Diniz-Lima","year":"2022","unstructured":"Diniz-Lima I, da Fonseca LM, Dos Reis JS, da Costa Rodrigues, Santos MA, Costa KM, do Nascimento Santos CA et al (2022) The sweet side of fungal infections: structural glycan diversity and its importance for pathogenic adaptation. Med 9(6):37. https:\/\/doi.org\/10.3390\/medicines9060037","journal-title":"Med"},{"issue":"7","key":"936_CR4","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/s1286-4579(03)00092-3","volume":"5","author":"JN Steenbergen","year":"2003","unstructured":"Steenbergen JN, Casadevall A (2003) The origin and maintenance of virulence for the human pathogenic fungus Cryptococcus neoformans. Microbes Infect 5(7):667\u2013675. https:\/\/doi.org\/10.1016\/s1286-4579(03)00092-3","journal-title":"Microbes Infect"},{"issue":"4","key":"936_CR5","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3390\/jof3040057","volume":"3","author":"F Bongomin","year":"2017","unstructured":"Bongomin F, Gago S, Oladele RO, Denning DW (2017) Global and multi-national prevalence of fungal diseases-estimate precision. J Fungi 3(4):57. https:\/\/doi.org\/10.3390\/jof3040057","journal-title":"J Fungi"},{"issue":"7","key":"936_CR6","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1007\/s00018-020-03736-z","volume":"78","author":"AB Strickland","year":"2021","unstructured":"Strickland AB, Shi M (2021) Mechanisms of fungal dissemination. Cell Mol Life Sci 78(7):3219\u20133238. https:\/\/doi.org\/10.1007\/s00018-020-03736-z","journal-title":"Cell Mol Life Sci"},{"issue":"4","key":"936_CR7","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.mib.2012.04.005","volume":"15","author":"NA Gow","year":"2012","unstructured":"Gow NA, Hube B (2012) Importance of the Candida albicans cell wall during commensalism and infection. Curr Opin Microbiol 15(4):406\u2013412. https:\/\/doi.org\/10.1016\/j.mib.2012.04.005","journal-title":"Curr Opin Microbiol"},{"issue":"5","key":"936_CR8","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.2214\/ajr.137.5.1033","volume":"137","author":"JJ Pagani","year":"1981","unstructured":"Pagani JJ, Libshitz HI (1981) Opportunistic fungal pneumonias in cancer patients. AJR Am J Roentgenol 137(5):1033\u20131039. https:\/\/doi.org\/10.2214\/ajr.137.5.1033","journal-title":"AJR Am J Roentgenol"},{"issue":"11","key":"936_CR9","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.tim.2011.07.010","volume":"19","author":"V Chaturvedi","year":"2011","unstructured":"Chaturvedi V, Chaturvedi S (2011) Cryptococcus gattii: a resurgent fungal pathogen. Trends Microbiol 19(11):564\u2013571. https:\/\/doi.org\/10.1016\/j.tim.2011.07.010","journal-title":"Trends Microbiol"},{"key":"936_CR10","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1146\/annurev.micro.62.081307.162753","volume":"63","author":"TL Doering","year":"2009","unstructured":"Doering TL (2009) How sweet it is! Cell wall biogenesis and polysaccharide capsule formation in Cryptococcus neoformans. Annu Rev Microbiol 63:223\u2013247. https:\/\/doi.org\/10.1146\/annurev.micro.62.081307.162753","journal-title":"Annu Rev Microbiol"},{"issue":"2","key":"936_CR11","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/nri.2017.111","volume":"18","author":"JF Bach","year":"2018","unstructured":"Bach JF (2018) The hygiene hypothesis in autoimmunity: the role of pathogens and commensals. Nat Rev Immunol 18(2):105\u2013120. https:\/\/doi.org\/10.1038\/nri.2017.111","journal-title":"Nat Rev Immunol"},{"key":"936_CR12","doi-asserted-by":"publisher","first-page":"637087","DOI":"10.3389\/fimmu.2021.637087","volume":"12","author":"H Garn","year":"2021","unstructured":"Garn H, Potaczek DP, Pfefferle PI (2021) The hygiene hypothesis and new perspectives-current challenges meeting an old postulate. Front Immunol 12:637087. https:\/\/doi.org\/10.3389\/fimmu.2021.637087","journal-title":"Front Immunol"},{"issue":"11","key":"936_CR13","doi-asserted-by":"publisher","first-page":"2834","DOI":"10.1158\/1078-0432.CCR-12-3661","volume":"19","author":"K Oikonomopoulou","year":"2013","unstructured":"Oikonomopoulou K, Brinc D, Kyriacou K, Diamandis EP (2013) Infection and cancer: revaluation of the hygiene hypothesis. Clin Cancer Res 19(11):2834\u20132841. https:\/\/doi.org\/10.1158\/1078-0432.CCR-12-3661","journal-title":"Clin Cancer Res"},{"issue":"1","key":"936_CR14","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/cei.13239","volume":"195","author":"U Christen","year":"2019","unstructured":"Christen U (2019) Pathogen infection and autoimmune disease. Clin Exp Immunol 195(1):10\u201314. https:\/\/doi.org\/10.1111\/cei.13239","journal-title":"Clin Exp Immunol"},{"issue":"7715","key":"936_CR15","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/s41586-018-0306-9","volume":"559","author":"M Ezzati","year":"2018","unstructured":"Ezzati M, Pearson-Stuttard J, Bennett JE, Mathers CD (2018) Acting on non-communicable diseases in low- and middle-income tropical countries. Nature 559(7715):507\u2013516. https:\/\/doi.org\/10.1038\/s41586-018-0306-9","journal-title":"Nature"},{"issue":"5","key":"936_CR16","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.aogh.2014.09.013","volume":"80","author":"JK Oh","year":"2014","unstructured":"Oh JK, Weiderpass E (2014) Infection and cancer: global distribution and burden of diseases. Ann Glob Health 80(5):384\u2013392. https:\/\/doi.org\/10.1016\/j.aogh.2014.09.013","journal-title":"Ann Glob Health"},{"issue":"9","key":"936_CR17","doi-asserted-by":"publisher","first-page":"3666","DOI":"10.1073\/pnas.72.9.3666","volume":"72","author":"EA Carswell","year":"1975","unstructured":"Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B (1975) An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 72(9):3666\u20133670. https:\/\/doi.org\/10.1073\/pnas.72.9.3666","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"936_CR18","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1289\/ehp.0800439","volume":"117","author":"JI Lundin","year":"2009","unstructured":"Lundin JI, Checkoway H (2009) Endotoxin and cancer. Environ Health Perspect 117(9):1344\u20131350. https:\/\/doi.org\/10.1289\/ehp.0800439","journal-title":"Environ Health Perspect"},{"issue":"10","key":"936_CR19","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1093\/carcin\/8.10.1543","volume":"8","author":"P Krogh","year":"1987","unstructured":"Krogh P, Hald B, Holmstrup P (1987) Possible mycological etiology of oral mucosal cancer: catalytic potential of infecting Candida albicans and other yeasts in production of N-nitrosobenzylmethylamine. Carcinogenesis 8(10):1543\u20131548. https:\/\/doi.org\/10.1093\/carcin\/8.10.1543","journal-title":"Carcinogenesis"},{"issue":"6","key":"936_CR20","doi-asserted-by":"publisher","first-page":"476","DOI":"10.3390\/jof7060476","volume":"7","author":"M Di Cosola","year":"2021","unstructured":"Di Cosola M, Cazzolla AP, Charitos IA, Ballini A, Inchingolo F, Santacroce L (2021) Candida albicans and oral carcinogenesis A brief review. J Fungi 7(6):476. https:\/\/doi.org\/10.3390\/jof7060476","journal-title":"J Fungi"},{"issue":"6","key":"936_CR21","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","volume":"140","author":"SI Grivennikov","year":"2010","unstructured":"Grivennikov SI, Greten FR, Karin M (2010) Immunity, inflammation, and cancer. Cell 140(6):883\u2013899. https:\/\/doi.org\/10.1016\/j.cell.2010.01.025","journal-title":"Cell"},{"issue":"Suppl 1","key":"936_CR22","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s10120-016-0650-0","volume":"20","author":"M Maeda","year":"2017","unstructured":"Maeda M, Moro H, Ushijima T (2017) Mechanisms for the induction of gastric cancer by Helicobacter pylori infection: aberrant DNA methylation pathway. Gastric Cancer 20(Suppl 1):8\u201315. https:\/\/doi.org\/10.1007\/s10120-016-0650-0","journal-title":"Gastric Cancer"},{"issue":"20","key":"936_CR23","doi-asserted-by":"publisher","first-page":"3789","DOI":"10.1016\/j.cell.2022.09.005","volume":"185","author":"L Narunsky-Haziza","year":"2022","unstructured":"Narunsky-Haziza L, Sepich-Poore GD, Livyatan I, Asraf O, Martino C, Nejman D et al (2022) Pan-cancer analyses reveal cancer-type-specific fungal ecologies and bacteriome interactions. Cell 185(20):3789\u2013806 e17. https:\/\/doi.org\/10.1016\/j.cell.2022.09.005","journal-title":"Cell"},{"issue":"7777","key":"936_CR24","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/s41586-019-1608-2","volume":"574","author":"B Aykut","year":"2019","unstructured":"Aykut B, Pushalkar S, Chen R, Li Q, Abengozar R, Kim JI et al (2019) The fungal mycobiome promotes pancreatic oncogenesis via activation of MBL. Nature 574(7777):264\u2013267. https:\/\/doi.org\/10.1038\/s41586-019-1608-2","journal-title":"Nature"},{"key":"936_CR25","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.ejca.2020.12.012","volume":"145","author":"M Skribek","year":"2021","unstructured":"Skribek M, Rounis K, Afshar S, Grundberg O, Friesland S, Tsakonas G et al (2021) Effect of corticosteroids on the outcome of patients with advanced non-small cell lung cancer treated with immune-checkpoint inhibitors. Eur J Cancer 145:245\u2013254. https:\/\/doi.org\/10.1016\/j.ejca.2020.12.012","journal-title":"Eur J Cancer"},{"key":"936_CR26","doi-asserted-by":"publisher","first-page":"100090","DOI":"10.1016\/j.crmicr.2021.100090","volume":"3","author":"MAL Huet","year":"2022","unstructured":"Huet MAL, Lee CZ, Rahman S (2022) A review on association of fungi with the development and progression of carcinogenesis in the human body. Curr Res Microb Sci 3:100090. https:\/\/doi.org\/10.1016\/j.crmicr.2021.100090","journal-title":"Curr Res Microb Sci"},{"issue":"6","key":"936_CR27","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.3390\/nu12061675","volume":"12","author":"PM Anderson","year":"2020","unstructured":"Anderson PM, Lalla RV (2020) Glutamine for amelioration of radiation and chemotherapy associated mucositis during cancer therapy. Nutrients 12(6):1675. https:\/\/doi.org\/10.3390\/nu12061675","journal-title":"Nutrients"},{"issue":"3","key":"936_CR28","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.critrevonc.2013.12.006","volume":"90","author":"GH Lyman","year":"2014","unstructured":"Lyman GH, Abella E, Pettengell R (2014) Risk factors for febrile neutropenia among patients with cancer receiving chemotherapy: a systematic review. Crit Rev Oncol Hematol 90(3):190\u2013199. https:\/\/doi.org\/10.1016\/j.critrevonc.2013.12.006","journal-title":"Crit Rev Oncol Hematol"},{"key":"936_CR29","doi-asserted-by":"publisher","first-page":"469","DOI":"10.2217\/fmb-2020-0006","volume":"15","author":"P Pagliano","year":"2020","unstructured":"Pagliano P, Esposito S, Ascione T, Spera AM (2020) Burden of fungal meningitis. Future Microbiol 15:469\u2013472. https:\/\/doi.org\/10.2217\/fmb-2020-0006","journal-title":"Future Microbiol"},{"issue":"1","key":"936_CR30","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jnci.2017.01.006","volume":"29","author":"GK Singh","year":"2017","unstructured":"Singh GK, Capoor MR, Nair D, Bhowmik KT (2017) Spectrum of fungal infection in head and neck cancer patients on chemoradiotherapy. J Egypt Natl Canc Inst 29(1):33\u201337. https:\/\/doi.org\/10.1016\/j.jnci.2017.01.006","journal-title":"J Egypt Natl Canc Inst"},{"issue":"2","key":"936_CR31","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1080\/14740338.2017.1270264","volume":"16","author":"I Kyriakidis","year":"2017","unstructured":"Kyriakidis I, Tragiannidis A, Munchen S, Groll AH (2017) Clinical hepatotoxicity associated with antifungal agents. Expert Opin Drug Saf 16(2):149\u2013165. https:\/\/doi.org\/10.1080\/14740338.2017.1270264","journal-title":"Expert Opin Drug Saf"},{"issue":"9","key":"936_CR32","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1080\/14740338.2021.1922667","volume":"20","author":"A Tragiannidis","year":"2021","unstructured":"Tragiannidis A, Gkampeta A, Vousvouki M, Vasileiou E, Groll AH (2021) Antifungal agents and the kidney: pharmacokinetics, clinical nephrotoxicity, and interactions. Expert Opin Drug Saf 20(9):1061\u20131074. https:\/\/doi.org\/10.1080\/14740338.2021.1922667","journal-title":"Expert Opin Drug Saf"},{"issue":"9","key":"936_CR33","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1080\/14740338.2016.1194824","volume":"15","author":"B Vincenzi","year":"2016","unstructured":"Vincenzi B, Armento G, Spalato Ceruso M, Catania G, Leakos M, Santini D et al (2016) Drug-induced hepatotoxicity in cancer patients - implication for treatment. Expert Opin Drug Saf 15(9):1219\u20131238. https:\/\/doi.org\/10.1080\/14740338.2016.1194824","journal-title":"Expert Opin Drug Saf"},{"issue":"12","key":"936_CR34","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.2215\/CJN.00150118","volume":"13","author":"MA Perazella","year":"2018","unstructured":"Perazella MA (2018) Pharmacology behind common drug nephrotoxicities. Clin J Am Soc Nephrol 13(12):1897\u20131908. https:\/\/doi.org\/10.2215\/CJN.00150118","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"936_CR35","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1177\/1078155218762624","volume":"25","author":"CR Rausch","year":"2019","unstructured":"Rausch CR, Kontoyiannis DP (2019) Prolonged voriconazole treatment in a patient with chronic lymphocytic leukemia resulting in a litany of chronic overlapping toxicities. J Oncol Pharm Pract 25(3):747\u2013753. https:\/\/doi.org\/10.1177\/1078155218762624","journal-title":"J Oncol Pharm Pract"},{"issue":"9","key":"936_CR36","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1093\/ajcp\/24.9.1050","volume":"24","author":"LE Zimmerman","year":"1954","unstructured":"Zimmerman LE, Rappaport H (1954) Occurrence of Cryptococcosis in patients with malignant disease of reticuloendothelial system. Am J Clin Pathol 24(9):1050\u20131072. https:\/\/doi.org\/10.1093\/ajcp\/24.9.1050","journal-title":"Am J Clin Pathol"},{"key":"936_CR37","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/978-3-319-04220-6_4","volume":"161","author":"M Angarone","year":"2014","unstructured":"Angarone M (2014) Fungal infections in cancer patients. Cancer Treat Res 161:129\u2013155. https:\/\/doi.org\/10.1007\/978-3-319-04220-6_4","journal-title":"Cancer Treat Res"},{"issue":"2","key":"936_CR38","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3109\/1040841X.2014.913004","volume":"42","author":"A Ramirez-Garcia","year":"2016","unstructured":"Ramirez-Garcia A, Rementeria A, Aguirre-Urizar JM, Moragues MD, Antoran A, Pellon A et al (2016) Candida albicans and cancer: can this yeast induce cancer development or progression? Crit Rev Microbiol 42(2):181\u2013193. https:\/\/doi.org\/10.3109\/1040841X.2014.913004","journal-title":"Crit Rev Microbiol"},{"issue":"1","key":"936_CR39","doi-asserted-by":"publisher","first-page":"e53584","DOI":"10.1371\/journal.pone.0053584","volume":"8","author":"A Ramirez-Garcia","year":"2013","unstructured":"Ramirez-Garcia A, Arteta B, Abad-Diaz-de-Cerio A, Pellon A, Antoran A, Marquez J et al (2013) Candida albicans increases tumor cell adhesion to endothelial cells in vitro: intraspecific differences and importance of the mannose receptor. PLoS One 8(1):e53584. https:\/\/doi.org\/10.1371\/journal.pone.0053584","journal-title":"PLoS One"},{"issue":"1","key":"936_CR40","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s10585-009-9300-9","volume":"27","author":"J Rodriguez-Cuesta","year":"2010","unstructured":"Rodriguez-Cuesta J, Hernando FL, Mendoza L, Gallot N, de Cerio AA, Martinez-de-Tejada G et al (2010) Candida albicans enhances experimental hepatic melanoma metastasis. Clin Exp Metastasis 27(1):35\u201342. https:\/\/doi.org\/10.1007\/s10585-009-9300-9","journal-title":"Clin Exp Metastasis"},{"issue":"1","key":"936_CR41","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s00253-011-3540-8","volume":"92","author":"A Ramirez-Garcia","year":"2011","unstructured":"Ramirez-Garcia A, Gallot N, Abad A, Mendoza L, Rementeria A, Hernando FL (2011) Molecular fractionation and characterization of a Candida albicans fraction that increases tumor cell adhesion to hepatic endothelium. Appl Microbiol Biotechnol 92(1):133\u2013145. https:\/\/doi.org\/10.1007\/s00253-011-3540-8","journal-title":"Appl Microbiol Biotechnol"},{"key":"936_CR42","doi-asserted-by":"publisher","unstructured":"Vadovics M, Ho J, Igaz N, Alfoldi R, Rakk D, Veres E, et al (2022) Candida albicans enhances the progression of oral squamous cell carcinoma in vitro and in vivo. mBio. e0314421. https:\/\/doi.org\/10.1128\/mBio.03144-21.","DOI":"10.1128\/mBio.03144-21"},{"key":"936_CR43","first-page":"1126","volume":"1","author":"U Kharadi","year":"2016","unstructured":"Kharadi U, Parkarwar P, Khairnar S, Arur P, Kulkarni T (2016) Oral candidiasis turns to oral cancer - a rare clinical presentation. Clin Oncol 1:1126","journal-title":"Clin Oncol"},{"issue":"8","key":"936_CR44","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1111\/odi.12565","volume":"22","author":"AD Alnuaimi","year":"2016","unstructured":"Alnuaimi AD, Ramdzan AN, Wiesenfeld D, O\u2019Brien-Simpson NM, Kolev SD, Reynolds EC et al (2016) Candida virulence and ethanol-derived acetaldehyde production in oral cancer and non-cancer subjects. Oral Dis 22(8):805\u2013814. https:\/\/doi.org\/10.1111\/odi.12565","journal-title":"Oral Dis"},{"issue":"9","key":"936_CR45","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1111\/jop.13014","volume":"49","author":"EAF Engku NasrullahSatiman","year":"2020","unstructured":"Engku NasrullahSatiman EAF, Ahmad H, Ramzi AB, Abdul Wahab R, Kaderi MA, Wan Harun WHA et al (2020) The role of Candida albicans candidalysin ECE1 gene in oral carcinogenesis. J Oral Pathol Med 49(9):835\u201341. https:\/\/doi.org\/10.1111\/jop.13014","journal-title":"J Oral Pathol Med"},{"issue":"1","key":"936_CR46","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3201\/eid0401.980109","volume":"4","author":"KL Buchanan","year":"1998","unstructured":"Buchanan KL, Murphy JW (1998) What makes Cryptococcus neoformans a pathogen? Emerg Infect Dis 4(1):71\u201383. https:\/\/doi.org\/10.3201\/eid0401.980109","journal-title":"Emerg Infect Dis"},{"issue":"11","key":"936_CR47","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1586\/eri.11.124","volume":"9","author":"M Caira","year":"2011","unstructured":"Caira M, Trecarichi EM, Tumbarello M, Leone G, Pagano L (2011) Uncommon yeast infections in hematological patients: from diagnosis to treatment. Expert Rev Anti Infect Ther 9(11):1067\u20131075. https:\/\/doi.org\/10.1586\/eri.11.124","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"3","key":"936_CR48","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3390\/jof7030212","volume":"7","author":"O Paccoud","year":"2021","unstructured":"Paccoud O, Bougnoux ME, Desnos-Ollivier M, Varet B, Lortholary O, Lanternier F (2021) Cryptococcus gattii in patients with lymphoid neoplasms: an illustration of evolutive host-fungus interactions. J Fungi 7(3):212. https:\/\/doi.org\/10.3390\/jof7030212","journal-title":"J Fungi"},{"issue":"9","key":"936_CR49","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1111\/myc.12496","volume":"59","author":"SA Schmalzle","year":"2016","unstructured":"Schmalzle SA, Buchwald UK, Gilliam BL, Riedel DJ (2016) Cryptococcus neoformans infection in malignancy. Mycoses 59(9):542\u2013552. https:\/\/doi.org\/10.1111\/myc.12496","journal-title":"Mycoses"},{"issue":"1","key":"936_CR50","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1038\/s41467-017-02126-7","volume":"8","author":"F Almeida","year":"2017","unstructured":"Almeida F, Wolf JM, da Silva TA, DeLeon-Rodriguez CM, Rezende CP, Pessoni AM et al (2017) Galectin-3 impacts Cryptococcus neoformans infection through direct antifungal effects. Nat Commun 8(1):1968. https:\/\/doi.org\/10.1038\/s41467-017-02126-7","journal-title":"Nat Commun"},{"issue":"1","key":"936_CR51","doi-asserted-by":"publisher","first-page":"16378","DOI":"10.1038\/s41598-018-34649-4","volume":"8","author":"IF LaRocque-de-Freitas","year":"2018","unstructured":"LaRocque-de-Freitas IF, Rocha JDB, Nunes MP, Oliveira PAV, Nascimento DO, Freire-de-Lima L et al (2018) Involvement of the capsular GalXM-induced IL-17 cytokine in the control of Cryptococcus neoformans infection. Sci Rep 8(1):16378. https:\/\/doi.org\/10.1038\/s41598-018-34649-4","journal-title":"Sci Rep"},{"key":"936_CR52","doi-asserted-by":"publisher","first-page":"8008","DOI":"10.1038\/srep08008","volume":"5","author":"JD Rocha","year":"2015","unstructured":"Rocha JD, Nascimento MT, Decote-Ricardo D, Corte-Real S, Morrot A, Heise N et al (2015) Capsular polysaccharides from Cryptococcus neoformans modulate production of neutrophil extracellular traps (NETs) by human neutrophils. Sci Rep 5:8008. https:\/\/doi.org\/10.1038\/srep08008","journal-title":"Sci Rep"},{"issue":"6","key":"936_CR53","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1111\/j.1462-5822.2008.01125.x","volume":"10","author":"SN Villena","year":"2008","unstructured":"Villena SN, Pinheiro RO, Pinheiro CS, Nunes MP, Takiya CM, DosReis GA et al (2008) Capsular polysaccharides galactoxylomannan and glucuronoxylomannan from Cryptococcus neoformans induce macrophage apoptosis mediated by Fas ligand. Cell Microbiol 10(6):1274\u20131285. https:\/\/doi.org\/10.1111\/j.1462-5822.2008.01125.x","journal-title":"Cell Microbiol"},{"issue":"2","key":"936_CR54","doi-asserted-by":"publisher","first-page":"147","DOI":"10.2217\/fmb.13.163","volume":"9","author":"PC Albuquerque","year":"2014","unstructured":"Albuquerque PC, Fonseca FL, Dutra FF, Bozza MT, Frases S, Casadevall A et al (2014) Cryptococcus neoformans glucuronoxylomannan fractions of different molecular masses are functionally distinct. Future Microbiol 9(2):147\u2013161. https:\/\/doi.org\/10.2217\/fmb.13.163","journal-title":"Future Microbiol"},{"key":"936_CR55","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3389\/fmed.2019.00129","volume":"6","author":"D Decote-Ricardo","year":"2019","unstructured":"Decote-Ricardo D, LaRocque-de-Freitas IF, Rocha JDB, Nascimento DO, Nunes MP, Morrot A et al (2019) Immunomodulatory role of capsular polysaccharides constituents of Cryptococcus neoformans. Front Med 6:129. https:\/\/doi.org\/10.3389\/fmed.2019.00129","journal-title":"Front Med"},{"issue":"9","key":"936_CR56","doi-asserted-by":"publisher","first-page":"3448","DOI":"10.1128\/iai.63.9.3448-3453.1995","volume":"63","author":"DL Goldman","year":"1995","unstructured":"Goldman DL, Lee SC, Casadevall A (1995) Tissue localization of Cryptococcus neoformans glucuronoxylomannan in the presence and absence of specific antibody. Infect Immun 63(9):3448\u20133453. https:\/\/doi.org\/10.1128\/iai.63.9.3448-3453.1995","journal-title":"Infect Immun"},{"issue":"5","key":"936_CR57","doi-asserted-by":"publisher","first-page":"612","DOI":"10.11150\/kansenshogakuzasshi1970.68.612","volume":"68","author":"S Yamamoto","year":"1994","unstructured":"Yamamoto S, Niki Y, Soejima R (1994) Fungal infection in hepatobiliary and pancreatic diseases: clinical evaluation in autopsy cases. Kansenshogaku Zasshi 68(5):612\u2013616. https:\/\/doi.org\/10.11150\/kansenshogakuzasshi1970.68.612","journal-title":"Kansenshogaku Zasshi"},{"issue":"4","key":"936_CR58","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1086\/322787","volume":"184","author":"M Grinsell","year":"2001","unstructured":"Grinsell M, Weinhold LC, Cutler JE, Han Y, Kozel TR (2001) In vivo clearance of glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformans: a critical role for tissue macrophages. J Infect Dis 184(4):479\u2013487. https:\/\/doi.org\/10.1086\/322787","journal-title":"J Infect Dis"},{"issue":"1","key":"936_CR59","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s12890-020-01200-z","volume":"20","author":"K Yao","year":"2020","unstructured":"Yao K, Qiu X, Hu H, Han Y, Zhang W, Xia R et al (2020) Pulmonary cryptococcosis coexisting with central type lung cancer in an immuocompetent patient: a case report and literature review. BMC Pulm Med 20(1):161. https:\/\/doi.org\/10.1186\/s12890-020-01200-z","journal-title":"BMC Pulm Med"},{"issue":"2","key":"936_CR60","doi-asserted-by":"publisher","first-page":"e18688","DOI":"10.1097\/MD.0000000000018688","volume":"99","author":"M Wei","year":"2020","unstructured":"Wei M, Xu YR, Liu K, Wen P (2020) Anastrozole-induced pulmonary cryptococcosis in a patient with early breast cancer: a case report. Medicine. 99(2):e18688. https:\/\/doi.org\/10.1097\/MD.0000000000018688","journal-title":"Medicine."},{"issue":"1","key":"936_CR61","doi-asserted-by":"publisher","first-page":"e77","DOI":"10.1016\/j.ijid.2009.03.007","volume":"14","author":"KW Ou","year":"2010","unstructured":"Ou KW, Hsu KF, Cheng YL, Hsu GC, Hsu HM, Yu JC (2010) Asymptomatic pulmonary nodules in a patient with early-stage breast cancer: Cryptococcus infection. Int J Infect Dis 14(1):e77-80. https:\/\/doi.org\/10.1016\/j.ijid.2009.03.007","journal-title":"Int J Infect Dis"},{"key":"936_CR62","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.12659\/ajcr.905528","volume":"18","author":"SI Shah","year":"2017","unstructured":"Shah SI, Bui H, Velasco N, Rungta S (2017) Incidental finding of Cryptococcus on prostate biopsy for prostate adenocarcinoma following cardiac transplant: case report and review of the literature. Am J Case Rep 18:1171\u20131180. https:\/\/doi.org\/10.12659\/ajcr.905528","journal-title":"Am J Case Rep"},{"key":"936_CR63","doi-asserted-by":"publisher","first-page":"2574964","DOI":"10.1155\/2022\/2574964","volume":"2022","author":"X Wang","year":"2022","unstructured":"Wang X, Zhou Z, Turner D, Lilly M, Ou T, Jiang W (2022) Differential circulating fungal microbiome in prostate cancer patients compared to healthy control individuals. J Immunol Res 2022:2574964. https:\/\/doi.org\/10.1155\/2022\/2574964","journal-title":"J Immunol Res"},{"issue":"4","key":"936_CR64","doi-asserted-by":"publisher","first-page":"e233860","DOI":"10.1136\/bcr-2019-233860","volume":"13","author":"SC Williams","year":"2020","unstructured":"Williams SC, Sweeney J, Parameswaran L (2020) Diagnostic and management considerations in the modern patient with AIDS: a case of concurrent disseminated Kaposi sarcoma and colesional Cryptococcus neoformans. BMJ Case Rep 13(4):e233860. https:\/\/doi.org\/10.1136\/bcr-2019-233860","journal-title":"BMJ Case Rep"},{"issue":"1","key":"936_CR65","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12941-020-00361-3","volume":"19","author":"LM Silva","year":"2020","unstructured":"Silva LM, Ferreira WA, Filho R, Lacerda MVG, Ferreira GMA, Saunier MN et al (2020) New ST623 of Cryptococcus neoformans isolated from a patient with non-Hodgkin\u2019s lymphoma in the Brazilian Amazon. Ann Clin Microbiol Antimicrob 19(1):20. https:\/\/doi.org\/10.1186\/s12941-020-00361-3","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"4","key":"936_CR66","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1080\/10428194.2018.1508666","volume":"60","author":"MV Dioverti","year":"2019","unstructured":"Dioverti MV, Parikh SA, Osmon DR, Habermann TM, Tande AJ (2019) Cryptococcus neoformans infections in patients with lymphoproliferative neoplasms. Leuk Lymphoma 60(4):920\u2013926. https:\/\/doi.org\/10.1080\/10428194.2018.1508666","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"936_CR67","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1080\/mmy.40.5.479.484","volume":"40","author":"D Averbuch","year":"2002","unstructured":"Averbuch D, Boekhoutt T, Falk R, Engelhard D, Shapiro M, Block C et al (2002) Fungemia in a cancer patient caused by fluconazole-resistant Cryptococcus laurentii. Med Mycol 40(5):479\u2013484. https:\/\/doi.org\/10.1080\/mmy.40.5.479.484","journal-title":"Med Mycol"},{"issue":"6","key":"936_CR68","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.bjid.2015.06.014","volume":"19","author":"RP Neves","year":"2015","unstructured":"Neves RP, Lima Neto RG, Leite MC, Silva VK, Santos Fde A, Macedo DP (2015) Cryptococcus laurentii fungaemia in a cervical cancer patient. Braz J Infect Dis 19(6):660\u2013663. https:\/\/doi.org\/10.1016\/j.bjid.2015.06.014","journal-title":"Braz J Infect Dis"},{"issue":"1","key":"936_CR69","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/pathogens5010006","volume":"5","author":"F Teoh","year":"2016","unstructured":"Teoh F, Pavelka N (2016) How chemotherapy increases the risk of systemic candidiasis in cancer patients: current paradigm and future directions. Pathog 5(1):6. https:\/\/doi.org\/10.3390\/pathogens5010006","journal-title":"Pathog"},{"key":"936_CR70","doi-asserted-by":"publisher","unstructured":"Infectious Diseases Working Party of the German Society of H, Oncology, Bohme A, Ruhnke M, Buchheidt D, Cornely OA, et al. Treatment of invasive fungal infections in cancer patients--recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol. 2009;88(2):97-110https:\/\/doi.org\/10.1007\/s00277-008-0622-5","DOI":"10.1007\/s00277-008-0622-5"},{"key":"936_CR71","doi-asserted-by":"publisher","unstructured":"Mota Fernandes C, Dasilva D, Haranahalli K, McCarthy JB, Mallamo J, Ojima I, et al. The future of antifungal drug therapy: novel compounds and targets. Antimicrob Agents Chemother. 2021;65(2). https:\/\/doi.org\/10.1128\/AAC.01719-20.","DOI":"10.1128\/AAC.01719-20"},{"issue":"9423","key":"936_CR72","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1016\/S0140-6736(04)16301-0","volume":"363","author":"AE Brouwer","year":"2004","unstructured":"Brouwer AE, Rajanuwong A, Chierakul W, Griffin GE, Larsen RA, White NJ et al (2004) Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial. Lancet 363(9423):1764\u20131767. https:\/\/doi.org\/10.1016\/S0140-6736(04)16301-0","journal-title":"Lancet"},{"key":"936_CR73","unstructured":"McKeny PT, Nessel TA, Zito PM (2022) Antifungal antibiotics. StatPearls. Treasure Island (FL)"},{"issue":"4","key":"936_CR74","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1542\/pir.16-4-123","volume":"16","author":"JT Cross Jr","year":"1995","unstructured":"Cross JT Jr, Hickerson SL, Yamauchi T (1995) Antifungal drugs. Pediatr Rev 16(4):123\u2013129. https:\/\/doi.org\/10.1542\/pir.16-4-123","journal-title":"Pediatr Rev"},{"issue":"1","key":"936_CR75","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1056\/NEJM199707033370103","volume":"337","author":"CM van der Horst","year":"1997","unstructured":"van der Horst CM, Saag MS, Cloud GA, Hamill RJ, Graybill JR, Sobel JD et al (1997) Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group. N Engl J Med 337(1):15\u201321. https:\/\/doi.org\/10.1056\/NEJM199707033370103","journal-title":"N Engl J Med"},{"issue":"4","key":"936_CR76","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1093\/jac\/dki288","volume":"56","author":"P Pitisuttithum","year":"2005","unstructured":"Pitisuttithum P, Negroni R, Graybill JR, Bustamante B, Pappas P, Chapman S et al (2005) Activity of posaconazole in the treatment of central nervous system fungal infections. J Antimicrob Chemother 56(4):745\u2013755. https:\/\/doi.org\/10.1093\/jac\/dki288","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"936_CR77","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1086\/313757","volume":"30","author":"MS Saag","year":"2000","unstructured":"Saag MS, Graybill RJ, Larsen RA, Pappas PG, Perfect JR, Powderly WG et al (2000) Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America. Clin Infect Dis. 30(4):710\u20138. https:\/\/doi.org\/10.1086\/313757","journal-title":"Clin Infect Dis."},{"issue":"2","key":"936_CR78","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.toxlet.2011.01.027","volume":"202","author":"Z Dvorak","year":"2011","unstructured":"Dvorak Z (2011) Drug-drug interactions by azole antifungals: beyond a dogma of CYP3A4 enzyme activity inhibition. Toxicol Lett 202(2):129\u2013132. https:\/\/doi.org\/10.1016\/j.toxlet.2011.01.027","journal-title":"Toxicol Lett"},{"issue":"6","key":"936_CR79","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1097\/QCO.0000000000000611","volume":"32","author":"J Lindsay","year":"2019","unstructured":"Lindsay J, Teh BW, Micklethwaite K, Slavin M (2019) Azole antifungals and new targeted therapies for hematological malignancy. Curr Opin Infect Dis 32(6):538\u2013545. https:\/\/doi.org\/10.1097\/QCO.0000000000000611","journal-title":"Curr Opin Infect Dis"},{"issue":"8","key":"936_CR80","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1007\/s40265-019-01127-8","volume":"79","author":"LL Benitez","year":"2019","unstructured":"Benitez LL, Carver PL (2019) Adverse effects associated with long-term administration of azole antifungal agents. Drugs 79(8):833\u2013853. https:\/\/doi.org\/10.1007\/s40265-019-01127-8","journal-title":"Drugs"},{"issue":"3","key":"936_CR81","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1530\/JOE-12-0310","volume":"215","author":"R van der Pas","year":"2012","unstructured":"van der Pas R, Hofland LJ, Hofland J, Taylor AE, Arlt W, Steenbergen J et al (2012) Fluconazole inhibits human adrenocortical steroidogenesis in vitro. J Endocrinol 215(3):403\u2013412. https:\/\/doi.org\/10.1530\/JOE-12-0310","journal-title":"J Endocrinol"},{"issue":"3","key":"936_CR82","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1097\/00003246-200103000-00039","volume":"29","author":"SG Albert","year":"2001","unstructured":"Albert SG, DeLeon MJ, Silverberg AB (2001) Possible association between high-dose fluconazole and adrenal insufficiency in critically ill patients. Crit Care Med 29(3):668\u2013670. https:\/\/doi.org\/10.1097\/00003246-200103000-00039","journal-title":"Crit Care Med"},{"issue":"3","key":"936_CR83","doi-asserted-by":"publisher","first-page":"375","DOI":"10.14740\/wjon890w","volume":"6","author":"F Carvalho","year":"2015","unstructured":"Carvalho F, Louro F, Zakout R (2015) Adrenal insufficiency in metastatic lung cancer. World J Oncol 6(3):375\u2013377. https:\/\/doi.org\/10.14740\/wjon890w","journal-title":"World J Oncol"},{"issue":"6","key":"936_CR84","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/bmt.2011.8","volume":"46","author":"B Wirk","year":"2011","unstructured":"Wirk B (2011) Renal failure in multiple myeloma: a medical emergency. Bone Marrow Transplant 46(6):771\u2013783. https:\/\/doi.org\/10.1038\/bmt.2011.8","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"936_CR85","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1530\/EJE-16-0969","volume":"176","author":"I Bancos","year":"2017","unstructured":"Bancos I, Hazeldine J, Chortis V, Hampson P, Taylor AE, Lord JM et al (2017) Primary adrenal insufficiency is associated with impaired natural killer cell function: a potential link to increased mortality. Eur J Endocrinol 176(4):471\u2013480. https:\/\/doi.org\/10.1530\/EJE-16-0969","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"936_CR86","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1513\/pats.200402-002MS","volume":"1","author":"MG Belvisi","year":"2004","unstructured":"Belvisi MG (2004) Regulation of inflammatory cell function by corticosteroids. Proc Am Thorac Soc 1(3):207\u2013214. https:\/\/doi.org\/10.1513\/pats.200402-002MS","journal-title":"Proc Am Thorac Soc"},{"issue":"7749","key":"936_CR87","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/s41586-019-1019-4","volume":"567","author":"MMS Obradovic","year":"2019","unstructured":"Obradovic MMS, Hamelin B, Manevski N, Couto JP, Sethi A, Coissieux MM et al (2019) Glucocorticoids promote breast cancer metastasis. Nature 567(7749):540\u2013544. https:\/\/doi.org\/10.1038\/s41586-019-1019-4","journal-title":"Nature"},{"issue":"10","key":"936_CR88","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/j.lpm.2019.09.021","volume":"48","author":"A Gompel","year":"2019","unstructured":"Gompel A (2019) Hormone and breast cancer. Presse Med 48(10):1085\u20131091. https:\/\/doi.org\/10.1016\/j.lpm.2019.09.021","journal-title":"Presse Med"},{"issue":"6","key":"936_CR89","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1007\/s43440-021-00317-0","volume":"73","author":"B Starek-Swiechowicz","year":"2021","unstructured":"Starek-Swiechowicz B, Budziszewska B, Starek A (2021) Endogenous estrogens-breast cancer and chemoprevention. Pharmacol Rep 73(6):1497\u20131512. https:\/\/doi.org\/10.1007\/s43440-021-00317-0","journal-title":"Pharmacol Rep"},{"issue":"3","key":"936_CR90","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1210\/endrev\/bnab002","volume":"42","author":"K Desai","year":"2021","unstructured":"Desai K, McManus JM, Sharifi N (2021) Hormonal therapy for prostate cancer. Endocr Rev 42(3):354\u2013373. https:\/\/doi.org\/10.1210\/endrev\/bnab002","journal-title":"Endocr Rev"},{"issue":"4","key":"936_CR91","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1080\/13685538.2018.1524456","volume":"22","author":"A Yassin","year":"2019","unstructured":"Yassin A, AlRumaihi K, Alzubaidi R, Alkadhi S, Al AA (2019) Testosterone, testosterone therapy and prostate cancer. Aging Male 22(4):219\u2013227. https:\/\/doi.org\/10.1080\/13685538.2018.1524456","journal-title":"Aging Male"},{"issue":"8","key":"936_CR92","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.urolonc.2020.04.008","volume":"38","author":"L Lenfant","year":"2020","unstructured":"Lenfant L, Leon P, Cancel-Tassin G, Audouin M, Staerman F, Roupret M et al (2020) Testosterone replacement therapy (TRT) and prostate cancer: an updated systematic review with a focus on previous or active localized prostate cancer. Urol Oncol 38(8):661\u2013670. https:\/\/doi.org\/10.1016\/j.urolonc.2020.04.008","journal-title":"Urol Oncol"},{"issue":"6","key":"936_CR93","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1001\/jamadermatol.2016.0351","volume":"152","author":"K Williams","year":"2016","unstructured":"Williams K, Arron ST (2016) Association of CYP2C19 *17\/*17 genotype with the risk of voriconazole-associated squamous cell carcinoma. JAMA Dermatol 152(6):719\u2013720. https:\/\/doi.org\/10.1001\/jamadermatol.2016.0351","journal-title":"JAMA Dermatol"},{"issue":"1","key":"936_CR94","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1111\/ajt.13431","volume":"16","author":"M Mansh","year":"2016","unstructured":"Mansh M, Binstock M, Williams K, Hafeez F, Kim J, Glidden D et al (2016) Voriconazole exposure and risk of cutaneous squamous cell carcinoma, Aspergillus colonization, invasive aspergillosis and death in lung transplant recipients. Am J Transplant 16(1):262\u2013270. https:\/\/doi.org\/10.1111\/ajt.13431","journal-title":"Am J Transplant"},{"issue":"6","key":"936_CR95","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1097\/DSS.0000000000000349","volume":"41","author":"VA Patel","year":"2015","unstructured":"Patel VA, Parikh SA, Nayyar PM, Ratner D (2015) Voriconazole-induced multiple squamous cell carcinomas in a patient with chronic lymphocytic leukemia. Dermatol Surg 41(6):747\u2013749. https:\/\/doi.org\/10.1097\/DSS.0000000000000349","journal-title":"Dermatol Surg"},{"issue":"12","key":"936_CR96","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.medmal.2011.09.016","volume":"41","author":"O Epaulard","year":"2011","unstructured":"Epaulard O, Leccia MT, Blanche S, Chosidow O, Mamzer-Bruneel MF, Ravaud P et al (2011) Phototoxicity and photocarcinogenesis associated with voriconazole. Med Mal Infect 41(12):639\u2013645. https:\/\/doi.org\/10.1016\/j.medmal.2011.09.016","journal-title":"Med Mal Infect"},{"issue":"7","key":"936_CR97","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1002\/ppul.21234","volume":"45","author":"MP Cheng","year":"2010","unstructured":"Cheng MP, Paquette K, Lands LC, Ovetchkine P, Theoret Y, Quach C (2010) Voriconazole inhibition of vitamin A metabolism: are adverse events increased in cystic fibrosis patients? Pediatr Pulmonol 45(7):661\u2013666. https:\/\/doi.org\/10.1002\/ppul.21234","journal-title":"Pediatr Pulmonol"},{"key":"936_CR98","doi-asserted-by":"publisher","unstructured":"Wang Q, He C (2020) Dietary vitamin A intake and the risk of ovarian cancer: a meta-analysis. Biosci Rep 40(4). https:\/\/doi.org\/10.1042\/BSR20193979","DOI":"10.1042\/BSR20193979"},{"issue":"12","key":"936_CR99","doi-asserted-by":"publisher","first-page":"3725","DOI":"10.1093\/jn\/nxab278","volume":"151","author":"KR Bitsie","year":"2021","unstructured":"Bitsie KR, Cheng TD, McCann SE, Zirpoli G, Yao S, Bandera EV et al (2021) Dietary vitamin A and breast cancer risk in Black women: the African American Breast Cancer Epidemiology and Risk (AMBER) consortium. J Nutr 151(12):3725\u20133737. https:\/\/doi.org\/10.1093\/jn\/nxab278","journal-title":"J Nutr"},{"issue":"1","key":"936_CR100","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41392-020-00213-8","volume":"5","author":"Z Zhang","year":"2020","unstructured":"Zhang Z, Zhou L, Xie N, Nice EC, Zhang T, Cui Y et al (2020) Overcoming cancer therapeutic bottleneck by drug repurposing. Signal Transduct Target Ther 5(1):113. https:\/\/doi.org\/10.1038\/s41392-020-00213-8","journal-title":"Signal Transduct Target Ther"},{"issue":"42","key":"936_CR101","doi-asserted-by":"publisher","first-page":"7214","DOI":"10.2174\/0929867327666191220103901","volume":"27","author":"LM Khachigian","year":"2020","unstructured":"Khachigian LM (2020) Repurposing drugs for skin cancer. Curr Med Chem 27(42):7214\u20137221. https:\/\/doi.org\/10.2174\/0929867327666191220103901","journal-title":"Curr Med Chem"},{"key":"936_CR102","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2022.08.018","author":"N Weng","year":"2022","unstructured":"Weng N, Zhang Z, Tan Y, Zhang X, Wei X, Zhu Q (2022) Repurposing antifungal drugs for cancer therapy. J Adv Res. https:\/\/doi.org\/10.1016\/j.jare.2022.08.018","journal-title":"J Adv Res"},{"issue":"18","key":"936_CR103","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1016\/j.lfs.2004.09.033","volume":"76","author":"HT Chang","year":"2005","unstructured":"Chang HT, Chen WC, Chen JS, Lu YC, Hsu SS, Wang JL et al (2005) Effect of miconazole on intracellular Ca2+ levels and proliferation in human osteosarcoma cells. Life Sci 76(18):2091\u20132101. https:\/\/doi.org\/10.1016\/j.lfs.2004.09.033","journal-title":"Life Sci"},{"issue":"2","key":"936_CR104","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.fct.2005.07.008","volume":"44","author":"KC Yang","year":"2006","unstructured":"Yang KC, Wu CC, Wu CH, Chen JH, Chu CH, Chen CH et al (2006) Involvement of proapoptotic Bcl-2 family members in terbinafine-induced mitochondrial dysfunction and apoptosis in HL60 cells. Food Chem Toxicol 44(2):214\u2013226. https:\/\/doi.org\/10.1016\/j.fct.2005.07.008","journal-title":"Food Chem Toxicol"},{"issue":"2","key":"936_CR105","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1006\/taap.2000.9062","volume":"169","author":"RJ Chen","year":"2000","unstructured":"Chen RJ, Lee WS, Liang YC, Lin JK, Wang YJ, Lin CH et al (2000) Ketoconazole induces G0\/G1 arrest in human colorectal and hepatocellular carcinoma cell lines. Toxicol Appl Pharmacol 169(2):132\u2013141. https:\/\/doi.org\/10.1006\/taap.2000.9062","journal-title":"Toxicol Appl Pharmacol"},{"key":"936_CR106","doi-asserted-by":"publisher","first-page":"828983","DOI":"10.3389\/fphar.2022.828983","volume":"13","author":"C Xu","year":"2022","unstructured":"Xu C, Zhuo Y, Liu Y, Chen H (2022) Itraconazole inhibits the growth of cutaneous squamous cell carcinoma by targeting HMGCS1\/ACSL4 axis. Front Pharmacol 13:828983. https:\/\/doi.org\/10.3389\/fphar.2022.828983","journal-title":"Front Pharmacol"},{"issue":"17","key":"936_CR107","doi-asserted-by":"publisher","first-page":"28510","DOI":"10.18632\/oncotarget.15324","volume":"8","author":"G Liang","year":"2017","unstructured":"Liang G, Liu M, Wang Q, Shen Y, Mei H, Li D et al (2017) Itraconazole exerts its anti-melanoma effect by suppressing Hedgehog, Wnt, and PI3K\/mTOR signaling pathways. Oncotarget 8(17):28510\u201328525. https:\/\/doi.org\/10.18632\/oncotarget.15324","journal-title":"Oncotarget"},{"issue":"7","key":"936_CR108","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.4161\/auto.28912","volume":"10","author":"R Liu","year":"2014","unstructured":"Liu R, Li J, Zhang T, Zou L, Chen Y, Wang K et al (2014) Itraconazole suppresses the growth of glioblastoma through induction of autophagy: involvement of abnormal cholesterol trafficking. Autophagy 10(7):1241\u20131255. https:\/\/doi.org\/10.4161\/auto.28912","journal-title":"Autophagy"},{"issue":"2","key":"936_CR109","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1002\/ps.4743","volume":"74","author":"DH Young","year":"2018","unstructured":"Young DH, Wang NX, Meyer ST, Avila-Adame C (2018) Characterization of the mechanism of action of the fungicide fenpicoxamid and its metabolite UK-2A. Pest Manag Sci 74(2):489\u2013498. https:\/\/doi.org\/10.1002\/ps.4743","journal-title":"Pest Manag Sci"},{"issue":"8","key":"936_CR110","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1094\/PHYTO-08-15-0186-R","volume":"106","author":"Y Zhou","year":"2016","unstructured":"Zhou Y, Xu J, Zhu Y, Duan Y, Zhou M (2016) Mechanism of action of the benzimidazole fungicide on Fusarium graminearum: interfering with polymerization of monomeric tubulin but not polymerized microtubule. Phytopathol 106(8):807\u2013813. https:\/\/doi.org\/10.1094\/PHYTO-08-15-0186-R","journal-title":"Phytopathol"},{"issue":"5","key":"936_CR111","doi-asserted-by":"publisher","first-page":"494","DOI":"10.4062\/biomolther.2018.042","volume":"26","author":"SH Bae","year":"2018","unstructured":"Bae SH, Park JH, Choi HG, Kim H, Kim SH (2018) Imidazole antifungal drugs inhibit the cell proliferation and invasion of human breast cancer cells. Biomol Ther 26(5):494\u2013502. https:\/\/doi.org\/10.4062\/biomolther.2018.042","journal-title":"Biomol Ther"},{"issue":"41","key":"936_CR112","doi-asserted-by":"publisher","first-page":"8653","DOI":"10.1021\/acs.jpcb.9b06009","volume":"123","author":"S Sarkar","year":"2019","unstructured":"Sarkar S, Singh PC (2019) Mechanistic aspects of fungicide-induced DNA damage: spectroscopic and molecular dynamics simulation studies. J Phys Chem B 123(41):8653\u20138661. https:\/\/doi.org\/10.1021\/acs.jpcb.9b06009","journal-title":"J Phys Chem B"},{"issue":"3","key":"936_CR113","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1002\/tox.23432","volume":"37","author":"R Li","year":"2022","unstructured":"Li R, Liu B, Xu W, Yu L, Zhang C, Cheng J et al (2022) DNA damage and cell apoptosis induced by fungicide difenoconazole in mouse mononuclear macrophage RAW264.7. Environ Toxicol 37(3):650\u20139. https:\/\/doi.org\/10.1002\/tox.23432","journal-title":"Environ Toxicol"},{"issue":"8","key":"936_CR114","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1200\/JCO.2013.49.9525","volume":"32","author":"DJ Kim","year":"2014","unstructured":"Kim DJ, Kim J, Spaunhurst K, Montoya J, Khodosh R, Chandra K et al (2014) Open-label, exploratory phase II trial of oral itraconazole for the treatment of basal cell carcinoma. J Clin Oncol 32(8):745\u2013751. https:\/\/doi.org\/10.1200\/JCO.2013.49.9525","journal-title":"J Clin Oncol"},{"issue":"5","key":"936_CR115","doi-asserted-by":"publisher","first-page":"768","DOI":"10.3892\/ol.2021.13029","volume":"22","author":"PW Shen","year":"2021","unstructured":"Shen PW, Chou YM, Li CL, Liao EC, Huang HS, Yin CH et al (2021) Itraconazole improves survival outcomes in patients with colon cancer by inducing autophagic cell death and inhibiting transketolase expression. Oncol Lett 22(5):768. https:\/\/doi.org\/10.3892\/ol.2021.13029","journal-title":"Oncol Lett"},{"issue":"4","key":"936_CR116","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1002\/mco2.102","volume":"2","author":"W Zhang","year":"2021","unstructured":"Zhang W, Zhou L, Qin S, Jiang J, Huang Z, Zhang Z et al (2021) Sertaconazole provokes proapoptotic autophagy via stabilizing TRADD in nonsmall cell lung cancer cells. MedComm 2(4):821\u201337. https:\/\/doi.org\/10.1002\/mco2.102","journal-title":"MedComm"},{"issue":"1","key":"936_CR117","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jhep.2018.09.022","volume":"70","author":"Y Chen","year":"2019","unstructured":"Chen Y, Chen HN, Wang K, Zhang L, Huang Z, Liu J et al (2019) Ketoconazole exacerbates mitophagy to induce apoptosis by downregulating cyclooxygenase-2 in hepatocellular carcinoma. J Hepatol 70(1):66\u201377. https:\/\/doi.org\/10.1016\/j.jhep.2018.09.022","journal-title":"J Hepatol"},{"key":"936_CR118","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/s0140-6736(97)90014-3","volume":"349","author":"A Harris","year":"1997","unstructured":"Harris A (1997) Antiangiogenesis for cancer therapy. Lancet 349:13\u201315. https:\/\/doi.org\/10.1016\/s0140-6736(97)90014-3","journal-title":"Lancet"},{"issue":"3","key":"936_CR119","doi-asserted-by":"publisher","first-page":"105886","DOI":"10.1016\/j.ijantimicag.2020.105886","volume":"55","author":"MS Copley","year":"2020","unstructured":"Copley MS, Waldron M, Athans V, Welch SC, Brizendine KD, Cober E et al (2020) Itraconazole vs. posaconazole for antifungal prophylaxis in patients with acute myeloid leukemia undergoing intensive chemotherapy: a retrospective study. Int J Antimicrob Agents 55(3):105886. https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.105886","journal-title":"Int J Antimicrob Agents"},{"issue":"3","key":"936_CR120","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1002\/med.21482","volume":"38","author":"M Xin","year":"2018","unstructured":"Xin M, Ji X, De La Cruz LK, Thareja S, Wang B (2018) Strategies to target the Hedgehog signaling pathway for cancer therapy. Med Res Rev 38(3):870\u2013913. https:\/\/doi.org\/10.1002\/med.21482","journal-title":"Med Res Rev"},{"issue":"2","key":"936_CR121","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.3892\/ol.2017.6325","volume":"14","author":"H Tsubamoto","year":"2017","unstructured":"Tsubamoto H, Ueda T, Inoue K, Sakata K, Shibahara H, Sonoda T (2017) Repurposing itraconazole as an anticancer agent. Oncol Lett 14(2):1240\u20131246. https:\/\/doi.org\/10.3892\/ol.2017.6325","journal-title":"Oncol Lett"},{"issue":"4","key":"936_CR122","doi-asserted-by":"publisher","first-page":"559","DOI":"10.3390\/pharmaceutics13040559","volume":"13","author":"J Lee","year":"2021","unstructured":"Lee J, Kang J, Kwon NY, Sivaraman A, Naik R, Jin SY et al (2021) Dual inhibition of P-gp and BCRP improves oral topotecan bioavailability in rodents. Pharm 13(4):559. https:\/\/doi.org\/10.3390\/pharmaceutics13040559","journal-title":"Pharm"},{"issue":"6","key":"936_CR123","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/nsmb.3216","volume":"23","author":"KP Locher","year":"2016","unstructured":"Locher KP (2016) Mechanistic diversity in ATP-binding cassette (ABC) transporters. Nat Struct Mol Biol 23(6):487\u2013493. https:\/\/doi.org\/10.1038\/nsmb.3216","journal-title":"Nat Struct Mol Biol"},{"issue":"5","key":"936_CR124","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1042\/BST20150047","volume":"43","author":"K Beis","year":"2015","unstructured":"Beis K (2015) Structural basis for the mechanism of ABC transporters. Biochem Soc Trans 43(5):889\u2013893. https:\/\/doi.org\/10.1042\/BST20150047","journal-title":"Biochem Soc Trans"},{"issue":"4","key":"936_CR125","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/yea.3356","volume":"36","author":"R Prasad","year":"2019","unstructured":"Prasad R, Balzi E, Banerjee A, Khandelwal NK (2019) All about CDR transporters: past, present, and future. Yeast 36(4):223\u2013233. https:\/\/doi.org\/10.1002\/yea.3356","journal-title":"Yeast"},{"issue":"4","key":"936_CR126","doi-asserted-by":"publisher","first-page":"497","DOI":"10.18388\/abp.1995_4902","volume":"42","author":"R Prasad","year":"1995","unstructured":"Prasad R, Murthy SK, Gupta V, Prasad R (1995) Multiple drug resistance in Candida albicans. Acta Biochim Pol 42(4):497\u2013504. https:\/\/doi.org\/10.18388\/abp.1995_4902","journal-title":"Acta Biochim Pol"},{"issue":"3","key":"936_CR127","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/s0924-8579(03)00213-9","volume":"22","author":"M Schuetzer-Muehlbauer","year":"2003","unstructured":"Schuetzer-Muehlbauer M, Willinger B, Egner R, Ecker G, Kuchler K (2003) Reversal of antifungal resistance mediated by ABC efflux pumps from Candida albicans functionally expressed in yeast. Int J Antimicrob Agents 22(3):291\u2013300. https:\/\/doi.org\/10.1016\/s0924-8579(03)00213-9","journal-title":"Int J Antimicrob Agents"},{"issue":"2","key":"936_CR128","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1128\/CMR.11.2.382","volume":"11","author":"TC White","year":"1998","unstructured":"White TC, Marr KA, Bowden RA (1998) Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin Microbiol Rev 11(2):382\u2013402. https:\/\/doi.org\/10.1128\/CMR.11.2.382","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"936_CR129","doi-asserted-by":"publisher","first-page":"132","DOI":"10.3109\/13693786.2010.512022","volume":"49","author":"G Kofla","year":"2011","unstructured":"Kofla G, Turner V, Schulz B, Storch U, Froelich D, Rognon B et al (2011) Doxorubicin induces drug efflux pumps in Candida albicans. Med Mycol 49(2):132\u2013142. https:\/\/doi.org\/10.3109\/13693786.2010.512022","journal-title":"Med Mycol"},{"key":"936_CR130","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/978-981-13-7647-4_12","volume":"1141","author":"H Amawi","year":"2019","unstructured":"Amawi H, Sim HM, Tiwari AK, Ambudkar SV, Shukla S (2019) ABC transporter-mediated multidrug-resistant cancer. Adv Exp Med Biol 1141:549\u2013580. https:\/\/doi.org\/10.1007\/978-981-13-7647-4_12","journal-title":"Adv Exp Med Biol"},{"issue":"9","key":"936_CR131","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1111\/jop.13050","volume":"49","author":"X Lu","year":"2020","unstructured":"Lu X, Wang Z, Huang H, Wang H (2020) Hedgehog signaling promotes multidrug resistance by regulation of ABC transporters in oral squamous cell carcinoma. J Oral Pathol Med 49(9):897\u2013906. https:\/\/doi.org\/10.1111\/jop.13050","journal-title":"J Oral Pathol Med"},{"issue":"2","key":"936_CR132","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s10719-022-10042-2","volume":"39","author":"LM da Fonseca","year":"2022","unstructured":"da Fonseca LM, da Silva VA, da Costa KM, Dos Reis JS, Previato JO, Previato LM et al (2022) Resistance to cisplatin in human lung adenocarcinoma cells: effects on the glycophenotype and epithelial to mesenchymal transition markers. Glycoconj J 39(2):247\u2013259. https:\/\/doi.org\/10.1007\/s10719-022-10042-2","journal-title":"Glycoconj J"},{"key":"936_CR133","doi-asserted-by":"publisher","first-page":"653306","DOI":"10.3389\/fphar.2021.653306","volume":"12","author":"T Wang","year":"2021","unstructured":"Wang T, Dong J, Yuan X, Wen H, Wu L, Liu J et al (2021) A new chalcone derivative C49 reverses doxorubicin resistance in MCF-7\/DOX cells by inhibiting P-glycoprotein expression. Front Pharmacol 12:653306. https:\/\/doi.org\/10.3389\/fphar.2021.653306","journal-title":"Front Pharmacol"},{"issue":"4","key":"936_CR134","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/S0733-8619(18)30254-8","volume":"9","author":"AA Pruitt","year":"1991","unstructured":"Pruitt AA (1991) Central nervous system infections in cancer patients. Neurol Clin 9(4):867\u2013888","journal-title":"Neurol Clin"},{"key":"936_CR135","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3389\/fcimb.2014.00106","volume":"4","author":"PA Teixeira","year":"2014","unstructured":"Teixeira PA, Penha LL, Mendonca-Previato L, Previato JO (2014) Mannoprotein MP84 mediates the adhesion of Cryptococcus neoformans to epithelial lung cells. Front Cell Infect Microbiol 4:106. https:\/\/doi.org\/10.3389\/fcimb.2014.00106","journal-title":"Front Cell Infect Microbiol"},{"issue":"3","key":"936_CR136","doi-asserted-by":"publisher","first-page":"e1007627","DOI":"10.1371\/journal.ppat.1007627","volume":"15","author":"LJ Heung","year":"2019","unstructured":"Heung LJ, Hohl TM (2019) Inflammatory monocytes are detrimental to the host immune response during acute infection with Cryptococcus neoformans. PLoS Pathog 15(3):e1007627. https:\/\/doi.org\/10.1371\/journal.ppat.1007627","journal-title":"PLoS Pathog"},{"issue":"4","key":"936_CR137","doi-asserted-by":"publisher","first-page":"869","DOI":"10.3892\/etm.2014.1517","volume":"7","author":"HJ Qin","year":"2014","unstructured":"Qin HJ, Feng QM, Fang Y, Shen L (2014) Type-I interferon secretion in the acute phase promotes Cryptococcus neoformans infection-induced Th17 cell polarization in vitro. Exp Ther Med 7(4):869\u2013872. https:\/\/doi.org\/10.3892\/etm.2014.1517","journal-title":"Exp Ther Med"},{"issue":"9","key":"936_CR138","doi-asserted-by":"publisher","first-page":"3880","DOI":"10.1128\/IAI.01773-14","volume":"82","author":"P Angkasekwinai","year":"2014","unstructured":"Angkasekwinai P, Sringkarin N, Supasorn O, Fungkrajai M, Wang YH, Chayakulkeeree M et al (2014) Cryptococcus gattii infection dampens Th1 and Th17 responses by attenuating dendritic cell function and pulmonary chemokine expression in the immunocompetent hosts. Infect Immun 82(9):3880\u20133890. https:\/\/doi.org\/10.1128\/IAI.01773-14","journal-title":"Infect Immun"},{"issue":"3","key":"936_CR139","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/j.1574-695X.2000.tb01430.x","volume":"27","author":"K Kawakami","year":"2000","unstructured":"Kawakami K, Qureshi MH, Zhang T, Koguchi Y, Yara S, Takeda K et al (2000) Involvement of endogenously synthesized interleukin (IL)-18 in the protective effects of IL-12 against pulmonary infection with Cryptococcus neoformans in mice. FEMS Immunol Med Microbiol 27(3):191\u2013200. https:\/\/doi.org\/10.1111\/j.1574-695X.2000.tb01430.x","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"4","key":"936_CR140","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1684\/ecn.2018.0401","volume":"28","author":"M Esmailbeig","year":"2017","unstructured":"Esmailbeig M, Ghaderi A (2017) Interleukin-18: a regulator of cancer and autoimmune diseases. Eur Cytokine Netw 28(4):127\u2013140. https:\/\/doi.org\/10.1684\/ecn.2018.0401","journal-title":"Eur Cytokine Netw"},{"issue":"5","key":"936_CR141","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.4049\/jimmunol.1300426","volume":"191","author":"A Flaczyk","year":"2013","unstructured":"Flaczyk A, Duerr CU, Shourian M, Lafferty EI, Fritz JH, Qureshi ST (2013) IL-33 signaling regulates innate and adaptive immunity to Cryptococcus neoformans. J Immunol 191(5):2503\u20132513. https:\/\/doi.org\/10.4049\/jimmunol.1300426","journal-title":"J Immunol"},{"issue":"1","key":"936_CR142","doi-asserted-by":"publisher","first-page":"18397","DOI":"10.1038\/s41598-021-97041-9","volume":"11","author":"I Diniz-Lima","year":"2021","unstructured":"Diniz-Lima I, da Rosa PR, da Silva-Junior EB, Guimaraes-de-Oliveira JC, de Freitas EO, de Oliveira ND et al (2021) X-linked immunodeficient (XID) mice exhibit high susceptibility to Cryptococcus gattii infection. Sci Rep 11(1):18397. https:\/\/doi.org\/10.1038\/s41598-021-97041-9","journal-title":"Sci Rep"},{"issue":"1","key":"936_CR143","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/cmi.12488","volume":"18","author":"I Garcia-Barbazan","year":"2016","unstructured":"Garcia-Barbazan I, Trevijano-Contador N, Rueda C, de Andres B, Perez-Tavarez R, Herrero-Fernandez I et al (2016) The formation of titan cells in Cryptococcus neoformans depends on the mouse strain and correlates with induction of Th2-type responses. Cell Microbiol 18(1):111\u2013124. https:\/\/doi.org\/10.1111\/cmi.12488","journal-title":"Cell Microbiol"},{"issue":"7","key":"936_CR144","doi-asserted-by":"publisher","first-page":"ftw086","DOI":"10.1093\/femspd\/ftw086","volume":"74","author":"L Heyen","year":"2016","unstructured":"Heyen L, Muller U, Siegemund S, Schulze B, Protschka M, Alber G et al (2016) Lung epithelium is the major source of IL-33 and is regulated by IL-33-dependent and IL-33-independent mechanisms in pulmonary cryptococcosis. Pathog Dis 74(7):ftw086. https:\/\/doi.org\/10.1093\/femspd\/ftw086","journal-title":"Pathog Dis"},{"key":"936_CR145","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.3389\/fimmu.2020.01598","volume":"11","author":"Z Sun","year":"2020","unstructured":"Sun Z, Ji N, Ma Q, Zhu R, Chen Z, Wang Z et al (2020) Epithelial-mesenchymal transition in asthma airway remodeling is regulated by the IL-33\/CD146 axis. Front Immunol 11:1598. https:\/\/doi.org\/10.3389\/fimmu.2020.01598","journal-title":"Front Immunol"},{"key":"936_CR146","doi-asserted-by":"publisher","unstructured":"Taniguchi S, Elhance A, Van Duzer A, Kumar S, Leitenberger JJ, Oshimori N (2020) Tumor-initiating cells establish an IL-33-TGF-beta niche signaling loop to promote cancer progression. Science. 369(6501). https:\/\/doi.org\/10.1126\/science.aay1813.","DOI":"10.1126\/science.aay1813"},{"issue":"1","key":"936_CR147","doi-asserted-by":"publisher","first-page":"365","DOI":"10.4049\/jimmunol.1501871","volume":"196","author":"DL Wiesner","year":"2016","unstructured":"Wiesner DL, Smith KD, Kotov DI, Nielsen JN, Bohjanen PR, Nielsen K (2016) Regulatory T cell induction and retention in the lungs drives suppression of detrimental type 2 Th cells during pulmonary cryptococcal infection. J Immunol 196(1):365\u2013374. https:\/\/doi.org\/10.4049\/jimmunol.1501871","journal-title":"J Immunol"},{"issue":"12","key":"936_CR148","doi-asserted-by":"publisher","first-page":"5999","DOI":"10.4049\/jimmunol.1402719","volume":"194","author":"AJ Eastman","year":"2015","unstructured":"Eastman AJ, He X, Qiu Y, Davis MJ, Vedula P, Lyons DM et al (2015) Cryptococcal heat shock protein 70 homolog Ssa1 contributes to pulmonary expansion of Cryptococcus neoformans during the afferent phase of the immune response by promoting macrophage M2 polarization. J Immunol 194(12):5999\u20136010. https:\/\/doi.org\/10.4049\/jimmunol.1402719","journal-title":"J Immunol"},{"issue":"9","key":"936_CR149","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/s41419-020-02926-8","volume":"11","author":"F Dong","year":"2020","unstructured":"Dong F, Ruan S, Wang J, Xia Y, Le K, Xiao X et al (2020) M2 macrophage-induced lncRNA PCAT6 facilitates tumorigenesis and angiogenesis of triple-negative breast cancer through modulation of VEGFR2. Cell Death Dis 11(9):728. https:\/\/doi.org\/10.1038\/s41419-020-02926-8","journal-title":"Cell Death Dis"},{"issue":"1","key":"936_CR150","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/cr.2016.151","volume":"27","author":"A Tanaka","year":"2017","unstructured":"Tanaka A, Sakaguchi S (2017) Regulatory T cells in cancer immunotherapy. Cell Res 27(1):109\u2013118. https:\/\/doi.org\/10.1038\/cr.2016.151","journal-title":"Cell Res"},{"issue":"3","key":"936_CR151","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1111\/cei.12725","volume":"183","author":"O Supasorn","year":"2016","unstructured":"Supasorn O, Sringkarin N, Srimanote P, Angkasekwinai P (2016) Matrix metalloproteinases contribute to the regulation of chemokine expression and pulmonary inflammation in Cryptococcus infection. Clin Exp Immunol 183(3):431\u2013440. https:\/\/doi.org\/10.1111\/cei.12725","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"936_CR152","doi-asserted-by":"publisher","first-page":"645","DOI":"10.3390\/cancers14030645","volume":"14","author":"N Berois","year":"2022","unstructured":"Berois N, Pittini A, Osinaga E (2022) Targeting tumor glycans for cancer therapy: successes, limitations, and perspectives. Cancers 14(3):645. https:\/\/doi.org\/10.3390\/cancers14030645","journal-title":"Cancers"},{"issue":"17","key":"936_CR153","doi-asserted-by":"publisher","first-page":"4248","DOI":"10.3390\/cancers14174248","volume":"14","author":"J Munkley","year":"2022","unstructured":"Munkley J (2022) Aberrant sialylation in cancer: therapeutic opportunities. Cancers 14(17):4248. https:\/\/doi.org\/10.3390\/cancers14174248","journal-title":"Cancers"},{"key":"936_CR154","doi-asserted-by":"publisher","unstructured":"Fernandes A, Azevedo CM, Silva MC, Faria G, Dantas CS, Vicente MM, et al. Glycans as shapers of tumour microenvironment: a sweet driver of T-cell-mediated anti-tumour immune response. Immunologyhttps:\/\/doi.org\/10.1111\/imm.13494","DOI":"10.1111\/imm.13494"},{"issue":"2","key":"936_CR155","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s10719-016-9755-2","volume":"34","author":"BN Vajaria","year":"2017","unstructured":"Vajaria BN, Patel PS (2017) Glycosylation: a hallmark of cancer? Glycoconj J 34(2):147\u2013156. https:\/\/doi.org\/10.1007\/s10719-016-9755-2","journal-title":"Glycoconj J"},{"issue":"6","key":"936_CR156","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3390\/medicines9060034","volume":"9","author":"JS Dos Reis","year":"2022","unstructured":"Dos Reis JS, da Costa Rodrigues, Santos MA, Mendonca DP, do Martins Nascimento SI, Barcelos PM, de Correia Lima RG et al (2022) Glycobiology of cancer: sugar drives the show. Med 9(6):34. https:\/\/doi.org\/10.3390\/medicines9060034","journal-title":"Med"},{"key":"936_CR157","doi-asserted-by":"publisher","unstructured":"dos Reis JS, Diniz-Lima I, Santos MARdC, Barcelos PM, da Costa KM, Valente RdC et al (2023) The blessed union of glycobiology and immunology: a marriage that worked. Med 10(2):15.\u00a0https:\/\/doi.org\/10.3390\/medicines10020015","DOI":"10.3390\/medicines10020015"},{"issue":"10","key":"936_CR158","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1158\/2326-6066.CIR-19-0904","volume":"8","author":"N Rodrigues Mantuano","year":"2020","unstructured":"Rodrigues Mantuano N, Stanczak MA, Oliveira IA, Kirchhammer N, Filardy AA, Monaco G et al (2020) Hyperglycemia enhances cancer immune evasion by inducing alternative macrophage polarization through increased O-GlcNAcylation. Cancer Immunol Res 8(10):1262\u20131272. https:\/\/doi.org\/10.1158\/2326-6066.CIR-19-0904","journal-title":"Cancer Immunol Res"},{"key":"936_CR159","doi-asserted-by":"publisher","first-page":"104285","DOI":"10.1016\/j.phrs.2019.104285","volume":"146","author":"NR Mantuano","year":"2019","unstructured":"Mantuano NR, Oliveira-Nunes MC, Alisson-Silva F, Dias WB, Todeschini AR (2019) Emerging role of glycosylation in the polarization of tumor-associated macrophages. Pharmacol Res. 146:104285. https:\/\/doi.org\/10.1016\/j.phrs.2019.104285","journal-title":"Pharmacol Res."},{"issue":"1","key":"936_CR160","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s12026-022-09321-9","volume":"71","author":"MAR da Costa Santos","year":"2023","unstructured":"da Costa Santos MAR, Dos Reis JS, do Nascimento Santos CA, Costa KM, Barcelos PM, de Oliveira Francisco KQ et al (2023) Expression of O-glycosylated oncofetal fibronectin in alternatively activated human macrophages. Immunol Res 71(1):92\u2013104. https:\/\/doi.org\/10.1007\/s12026-022-09321-9","journal-title":"Immunol Res"},{"issue":"43","key":"936_CR161","doi-asserted-by":"publisher","first-page":"17690","DOI":"10.1073\/pnas.1115191108","volume":"108","author":"L Freire-de-Lima","year":"2011","unstructured":"Freire-de-Lima L, Gelfenbeyn K, Ding Y, Mandel U, Clausen H, Handa K et al (2011) Involvement of O-glycosylation defining oncofetal fibronectin in epithelial-mesenchymal transition process. Proc Natl Acad Sci USA 108(43):17690\u201317695. https:\/\/doi.org\/10.1073\/pnas.1115191108","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"13","key":"936_CR162","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1016\/j.febslet.2012.05.020","volume":"586","author":"Y Ding","year":"2012","unstructured":"Ding Y, Gelfenbeyn K, Freire-de-Lima L, Handa K, Hakomori SI (2012) Induction of epithelial-mesenchymal transition with O-glycosylated oncofetal fibronectin. FEBS Lett 586(13):1813\u20131820. https:\/\/doi.org\/10.1016\/j.febslet.2012.05.020","journal-title":"FEBS Lett"},{"issue":"4","key":"936_CR163","doi-asserted-by":"publisher","first-page":"e60471","DOI":"10.1371\/journal.pone.0060471","volume":"8","author":"F Alisson-Silva","year":"2013","unstructured":"Alisson-Silva F, Freire-de-Lima L, Donadio JL, Lucena MC, Penha L, Sa-Diniz JN et al (2013) Increase of O-glycosylated oncofetal fibronectin in high glucose-induced epithelial-mesenchymal transition of cultured human epithelial cells. PLoS One 8(4):e60471. https:\/\/doi.org\/10.1371\/journal.pone.0060471","journal-title":"PLoS One"},{"issue":"9","key":"936_CR164","doi-asserted-by":"publisher","first-page":"101042832095750","DOI":"10.1177\/1010428320957506","volume":"42","author":"LM da Fonseca","year":"2020","unstructured":"da Fonseca LM, Calvalhan DM, Previato JO, Mendonca Previato L, Freire-de-Lima L (2020) Resistance to paclitaxel induces glycophenotype changes and mesenchymal-to-epithelial transition activation in the human prostate cancer cell line PC-3. Tumour Biol 42(9):1010428320957506. https:\/\/doi.org\/10.1177\/1010428320957506","journal-title":"Tumour Biol"},{"key":"936_CR165","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3389\/fonc.2014.00059","volume":"4","author":"L Freire-de-Lima","year":"2014","unstructured":"Freire-de-Lima L (2014) Sweet and sour: the impact of differential glycosylation in cancer cells undergoing epithelial-mesenchymal transition. Front Oncol 4:59. https:\/\/doi.org\/10.3389\/fonc.2014.00059","journal-title":"Front Oncol"},{"key":"936_CR166","doi-asserted-by":"publisher","first-page":"158","DOI":"10.3389\/fonc.2016.00158","volume":"6","author":"LM da Fonseca","year":"2016","unstructured":"da Fonseca LM, da Silva VA, Freire-de-Lima L, Previato JO, Mendonca-Previato L, Capella MA (2016) Glycosylation in cancer: interplay between multidrug resistance and epithelial-to-mesenchymal transition? Front Oncol 6:158. https:\/\/doi.org\/10.3389\/fonc.2016.00158","journal-title":"Front Oncol"},{"issue":"50","key":"936_CR167","doi-asserted-by":"publisher","first-page":"e18316","DOI":"10.1097\/MD.0000000000018316","volume":"98","author":"J Huang","year":"2019","unstructured":"Huang J, Lan C, Li H, Chen S, Lin Q, Weng H (2019) Concomitant lung adenocarcinoma and pulmonary cryptococcosis confirmed by pathologic examinations. Med 98(50):e18316. https:\/\/doi.org\/10.1097\/MD.0000000000018316","journal-title":"Med"},{"issue":"3","key":"936_CR168","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1177\/10781552211066073","volume":"28","author":"M Ugrakli","year":"2022","unstructured":"Ugrakli M, Araz M, Demirkiran A, Celik AF, Karakurt Eryilmaz M, Karaagac M et al (2022) Pneumonitis associated with trastuzumab emtansine in a patient with metastatic breast cancer. J Oncol Pharm Pract 28(3):740\u2013745. https:\/\/doi.org\/10.1177\/10781552211066073","journal-title":"J Oncol Pharm Pract"},{"issue":"6","key":"936_CR169","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1111\/jocd.13158","volume":"19","author":"YZ Ji","year":"2020","unstructured":"Ji YZ, Ma ZM, Chang L, Liu SR (2020) A novel case of cutaneous squamous cell carcinoma at the site of previous sporotrichosis. J Cosmet Dermatol 19(6):1487\u20131489. https:\/\/doi.org\/10.1111\/jocd.13158","journal-title":"J Cosmet Dermatol"},{"issue":"9","key":"936_CR170","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.47391\/JPMA.4632","volume":"72","author":"S Aslam","year":"2022","unstructured":"Aslam S, Ghafoor S (2022) Association of Candida species with novel SARS-CoV-2 and biomarkers for fungal premalignant oral lesions. J Pak Med Assoc 72(9):1827\u20131830. https:\/\/doi.org\/10.47391\/JPMA.4632","journal-title":"J Pak Med Assoc"},{"key":"936_CR171","doi-asserted-by":"publisher","first-page":"135","DOI":"10.11604\/pamj.2022.42.135.34116","volume":"42","author":"A Badheeb","year":"2022","unstructured":"Badheeb A, Al Gharem N, Al Hammadi S, Elsagheer S, Badheeb M, Ahmed F (2022) Primary pulmonary leiomyosarcoma with coexistent pulmonary aspergillosis: a case report. Pan Afr Med J 42:135. https:\/\/doi.org\/10.11604\/pamj.2022.42.135.34116","journal-title":"Pan Afr Med J"},{"issue":"1","key":"936_CR172","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.bbcan.2019.07.002","volume":"1872","author":"M Scimeca","year":"2019","unstructured":"Scimeca M, Urbano N, Bonfiglio R, Duggento A, Toschi N, Schillaci O et al (2019) Novel insights into breast cancer progression and metastasis: a multidisciplinary opportunity to transition from biology to clinical oncology. Biochim Biophys Acta Rev Cancer 1872(1):138\u2013148. https:\/\/doi.org\/10.1016\/j.bbcan.2019.07.002","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"3","key":"936_CR173","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/tbj.14159","volume":"27","author":"I Barco","year":"2021","unstructured":"Barco I, Garcia-Font M, Garcia-Fernandez A, Fraile M, Gimenez N, Gonzalez S et al (2021) Breast cancer patients developing distant metastasis at follow-up: mortality-related factors. Breast J 27(3):291\u2013293. https:\/\/doi.org\/10.1111\/tbj.14159","journal-title":"Breast J"},{"issue":"6","key":"936_CR174","doi-asserted-by":"publisher","first-page":"3297","DOI":"10.1021\/acs.chemrev.0c00383","volume":"121","author":"RA Ward","year":"2021","unstructured":"Ward RA, Fawell S, Floc\u2019h N, Flemington V, McKerrecher D, Smith PD (2021) Challenges and opportunities in cancer drug resistance. Chem Rev. 121(6):3297\u2013351. https:\/\/doi.org\/10.1021\/acs.chemrev.0c00383","journal-title":"Chem Rev."},{"issue":"7","key":"936_CR175","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1007\/s00204-021-03063-7","volume":"95","author":"RJ De Las","year":"2021","unstructured":"De Las RJ, Brozovic A, Izraely S, Casas-Pais A, Witz IP, Figueroa A (2021) Cancer drug resistance induced by EMT: novel therapeutic strategies. Arch Toxicol 95(7):2279\u20132297. https:\/\/doi.org\/10.1007\/s00204-021-03063-7","journal-title":"Arch Toxicol"},{"issue":"1","key":"936_CR176","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12964-020-00627-5","volume":"19","author":"Y Li","year":"2021","unstructured":"Li Y, Wang Z, Ajani JA, Song S (2021) Drug resistance and cancer stem cells. Cell Commun Signal 19(1):19. https:\/\/doi.org\/10.1186\/s12964-020-00627-5","journal-title":"Cell Commun Signal"},{"issue":"3","key":"936_CR177","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1046\/j.1365-2567.1997.00357.x","volume":"92","author":"R Blackstock","year":"1997","unstructured":"Blackstock R, Casadevall A (1997) Presentation of cryptococcal capsular polysaccharide (GXM) on activated antigen-presenting cells inhibits the T-suppressor response and enhances delayed-type hypersensitivity and survival. Immunol 92(3):334\u2013339. https:\/\/doi.org\/10.1046\/j.1365-2567.1997.00357.x","journal-title":"Immunol"},{"issue":"1\u20132","key":"936_CR178","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/s0165-5728(00)00354-4","volume":"111","author":"MM Lipovsky","year":"2000","unstructured":"Lipovsky MM, Tsenova L, Coenjaerts FE, Kaplan G, Cherniak R, Hoepelman AI (2000) Cryptococcal glucuronoxylomannan delays translocation of leukocytes across the blood-brain barrier in an animal model of acute bacterial meningitis. J Neuroimmunol 111(1\u20132):10\u201314. https:\/\/doi.org\/10.1016\/s0165-5728(00)00354-4","journal-title":"J Neuroimmunol"},{"issue":"2","key":"936_CR179","doi-asserted-by":"publisher","first-page":"253","DOI":"10.2174\/0929867043456188","volume":"11","author":"PM Ellerbroek","year":"2004","unstructured":"Ellerbroek PM, Walenkamp AM, Hoepelman AI, Coenjaerts FE (2004) Effects of the capsular polysaccharides of Cryptococcus neoformans on phagocyte migration and inflammatory mediators. Curr Med Chem 11(2):253\u2013266. https:\/\/doi.org\/10.2174\/0929867043456188","journal-title":"Curr Med Chem"},{"issue":"11","key":"936_CR180","doi-asserted-by":"publisher","first-page":"4368","DOI":"10.1128\/iai.63.11.4368-4374.1995","volume":"63","author":"AS Ibrahim","year":"1995","unstructured":"Ibrahim AS, Filler SG, Alcouloumre MS, Kozel TR, Edwards JE Jr, Ghannoum MA (1995) Adherence to and damage of endothelial cells by Cryptococcus neoformans in vitro: role of the capsule. Infect Immun 63(11):4368\u20134374. https:\/\/doi.org\/10.1128\/iai.63.11.4368-4374.1995","journal-title":"Infect Immun"},{"issue":"3","key":"936_CR181","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1111\/j.1365-2567.2004.01970.x","volume":"113","author":"LS Chiapello","year":"2004","unstructured":"Chiapello LS, Baronetti JL, Aoki MP, Gea S, Rubinstein H, Masih DT (2004) Immunosuppression, interleukin-10 synthesis and apoptosis are induced in rats inoculated with Cryptococcus neoformans glucuronoxylomannan. Immunol 113(3):392\u2013400. https:\/\/doi.org\/10.1111\/j.1365-2567.2004.01970.x","journal-title":"Immunol"},{"issue":"4","key":"936_CR182","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1080\/1369378031000137260","volume":"41","author":"LS Chiapello","year":"2003","unstructured":"Chiapello LS, Aoki MP, Rubinstein HR, Masih DT (2003) Apoptosis induction by glucuronoxylomannan of Cryptococcus neoformans. Med Mycol 41(4):347\u2013353. https:\/\/doi.org\/10.1080\/1369378031000137260","journal-title":"Med Mycol"},{"issue":"2","key":"936_CR183","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1128\/IAI.66.2.664-669.1998","volume":"66","author":"C Retini","year":"1998","unstructured":"Retini C, Vecchiarelli A, Monari C, Bistoni F, Kozel TR (1998) Encapsulation of Cryptococcus neoformans with glucuronoxylomannan inhibits the antigen-presenting capacity of monocytes. Infect Immun 66(2):664\u2013669. https:\/\/doi.org\/10.1128\/IAI.66.2.664-669.1998","journal-title":"Infect Immun"},{"issue":"11","key":"936_CR184","doi-asserted-by":"publisher","first-page":"e120","DOI":"10.1371\/journal.ppat.0020120","volume":"2","author":"LE Yauch","year":"2006","unstructured":"Yauch LE, Lam JS, Levitz SM (2006) Direct inhibition of T-cell responses by the Cryptococcus capsular polysaccharide glucuronoxylomannan. PLoS Pathog. 2(11):e120. https:\/\/doi.org\/10.1371\/journal.ppat.0020120","journal-title":"PLoS Pathog."},{"issue":"2","key":"936_CR185","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1128\/iai.74.2.896-903.2006","volume":"74","author":"N Jain","year":"2006","unstructured":"Jain N, Li L, McFadden DC, Banarjee U, Wang X, Cook E et al (2006) Phenotypic switching in a Cryptococcus neoformans variety gattii strain is associated with changes in virulence and promotes dissemination to the central nervous system. Infect Immun 74(2):896\u2013903. https:\/\/doi.org\/10.1128\/iai.74.2.896-903.2006","journal-title":"Infect Immun"},{"issue":"19","key":"936_CR186","doi-asserted-by":"publisher","first-page":"15298","DOI":"10.1074\/jbc.M112.353375","volume":"287","author":"A Jong","year":"2012","unstructured":"Jong A, Wu CH, Gonzales-Gomez I, Kwon-Chung KJ, Chang YC, Tseng HK et al (2012) Hyaluronic acid receptor CD44 deficiency is associated with decreased Cryptococcus neoformans brain infection. J Biol Chem 287(19):15298\u201315306. https:\/\/doi.org\/10.1074\/jbc.M112.353375","journal-title":"J Biol Chem"},{"issue":"1","key":"936_CR187","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13045-018-0605-5","volume":"11","author":"C Chen","year":"2018","unstructured":"Chen C, Zhao S, Karnad A, Freeman JW (2018) The biology and role of CD44 in cancer progression: therapeutic implications. J Hematol Oncol 11(1):64. https:\/\/doi.org\/10.1186\/s13045-018-0605-5","journal-title":"J Hematol Oncol"},{"issue":"6766","key":"936_CR188","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/35003208","volume":"403","author":"CG Freire-de-Lima","year":"2000","unstructured":"Freire-de-Lima CG, Nascimento DO, Soares MB, Bozza PT, Castro-Faria-Neto HC, de Mello FG et al (2000) Uptake of apoptotic cells drives the growth of a pathogenic trypanosome in macrophages. Nature 403(6766):199\u2013203. https:\/\/doi.org\/10.1038\/35003208","journal-title":"Nature"},{"issue":"5","key":"936_CR189","doi-asserted-by":"publisher","first-page":"3575","DOI":"10.4049\/jimmunol.181.5.3575","volume":"181","author":"YQ Xiao","year":"2008","unstructured":"Xiao YQ, Freire-de-Lima CG, Schiemann WP, Bratton DL, Vandivier RW, Henson PM (2008) Transcriptional and translational regulation of TGF-beta production in response to apoptotic cells. J Immunol 181(5):3575\u20133585. https:\/\/doi.org\/10.4049\/jimmunol.181.5.3575","journal-title":"J Immunol"},{"issue":"8","key":"936_CR190","doi-asserted-by":"publisher","first-page":"e12869","DOI":"10.1111\/cpr.12869","volume":"53","author":"Y Hao","year":"2020","unstructured":"Hao Y, Huang Y, Chen J, Li J, Yuan Y, Wang M et al (2020) Exopolysaccharide from Cryptococcus heimaeyensis S20 induces autophagic cell death in non-small cell lung cancer cells via ROS\/p38 and ROS\/ERK signalling. Cell Prolif 53(8):e12869. https:\/\/doi.org\/10.1111\/cpr.12869","journal-title":"Cell Prolif"},{"issue":"10","key":"936_CR191","doi-asserted-by":"publisher","first-page":"6064","DOI":"10.1128\/IAI.69.10.6064-6073.2001","volume":"69","author":"C Retini","year":"2001","unstructured":"Retini C, Kozel TR, Pietrella D, Monari C, Bistoni F, Vecchiarelli A (2001) Interdependency of interleukin-10 and interleukin-12 in regulation of T-cell differentiation and effector function of monocytes in response to stimulation with Cryptococcus neoformans. Infect Immun 69(10):6064\u20136073. https:\/\/doi.org\/10.1128\/IAI.69.10.6064-6073.2001","journal-title":"Infect Immun"}],"container-title":["Brazilian Journal of Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42770-023-00936-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s42770-023-00936-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42770-023-00936-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T02:16:12Z","timestamp":1685672172000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s42770-023-00936-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,25]]},"references-count":191,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["936"],"URL":"https:\/\/doi.org\/10.1007\/s42770-023-00936-0","relation":{},"ISSN":["1517-8382","1678-4405"],"issn-type":[{"value":"1517-8382","type":"print"},{"value":"1678-4405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,25]]},"assertion":[{"value":"26 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"All authors have read and agreed to the published version of the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}